Skip to content

H.Res. 1521 · 118th Congress (2023–2025)

Expressing support for the designation of September 30, 2024, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

This resolution expresses support for the designation of Rare Cancer Day.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is H.Res. 1521’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Mike Kelly (R-PA-16)
Cosponsors
4 cosponsors

4 original · 0 later

  1. Rep. Debbie Dingell (D-MI-6)· Original · Sep 27, 2024
  2. Rep. Brian K. Fitzpatrick (R-PA-1)· Original · Sep 27, 2024
  3. Rep. Derek Kilmer (D-WA-6)· Original · Sep 27, 2024
  4. Rep. Debbie Wasserman Schultz (D-FL-25)· Original · Sep 27, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources
  3. Expired

    Introduced → Referred to House Energy and Commerce → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Sep 27, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (1)
  1. Expressing support for the designation of September 30, 2024, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

    Official title, Display title · Introduced in House